What actually helps with prostate symptoms
Weak stream, going often, getting up at night — the lower urinary tract symptoms of an enlarging prostate. The placebo response here is large, so an effect has to clear that bar to mean anything.
Beta-Sitosterol for Prostate Symptoms
Solid1 study · 1 supporting · 0 against
A plant sterol structurally similar to cholesterol, proposed to affect prostaglandin metabolism and 5-alpha-reductase activity, though the exact mechanism in the prostate is not established.
Dose: 60–130 mg
Tested as: Non-glucosidic beta-sitosterol (e.g. Harzol, Azuprostat brands), 20 mg three times daily (60 mg/day) in Berges 1995, or 130 mg/day free beta-sitosterol in Klippel 1997; one pooled trial used a beta-sitosteryl-beta-D-glucoside preparation.
Pygeum Africanum for Prostate Symptoms
Mixed2 studies · 1 supporting · 1 against
Contains phytosterols and pentacyclic triterpenoids proposed to have anti-inflammatory and anti-proliferative effects on prostate tissue; exact mechanism unclear.
Dose: 100–200 mg
Tested as: Pygeum africanum bark extract standardized to ~14% sterols, typically 50 mg twice daily or 100 mg once daily (branded as Tadenan in several European trials).
Rye Grass Pollen Extract (Cernilton) for Prostate Symptoms
Evidence1 study · 1 supporting · 0 against
Proposed to relax the bladder neck/urethral smooth muscle and have mild anti-inflammatory, anti-androgenic effects on the prostate; mechanism not firmly established.
Dose: 252–378 mg
Tested as: Cernilton (standardized rye grass/Secale cereale pollen extract, brand Cernitin), typically 126 mg two to three times daily (252-378 mg/day).
Saw Palmetto for Prostate Symptoms
No Benefit4 studies · 0 supporting · 3 against
8 safety notes
How it was tested: Dose escalation to 320, then 640, then 960 mg/day over 72 weeks produced no benefit over placebo on AUA symptom score or any secondary measure (flow rate, prostate volume, PSA, nocturia, quality of life). This is the CAMUS trial.
Proposed to inhibit 5-alpha-reductase and reduce inflammatory/growth signaling in prostate tissue, lowering intraprostatic DHT; this has not translated into a measurable symptom benefit in rigorous trials.
Dose: 320–960 mg
Tested as: Saw palmetto (Serenoa repens) berry extract. STEP trial used 160 mg twice daily (320 mg/day); CAMUS trial dose-escalated the same 320 mg/day extract to 640 mg/day then 960 mg/day (3x usual dose) over 72 weeks. Neither trial used the hexane-extracted lipidosterolic preparation (Permixon) specifically, and the Cochrane review pooled 27 trials of varying extracts/solvents.
Stinging Nettle Root for Prostate Symptoms
No Benefit2 studies · 0 supporting · 1 against
How it was tested: 300 mg nettle + 25 mg pygeum produced clinical and urodynamic effects similar to placebo (combination product, not nettle alone).
Proposed to inhibit sex-hormone-binding globulin (SHBG) binding and have mild anti-inflammatory/aromatase-inhibiting effects relevant to prostate tissue.
Dose: 360–1200 mg
Tested as: Urtica dioica root extract; aqueous extracts studied at 360 mg/day over 6 months, methanol extracts at 600-1,200 mg/day over 6-9 weeks — no standardized preparation across trials.
Lycopene for Prostate Symptoms
No Benefit1 study · 0 supporting · 1 against
How it was tested: 8 RCTs identified; high clinical heterogeneity precluded pooled meta-analysis of most outcomes. Explicit conclusion: evidence is insufficient to support or refute lycopene for BPH or prostate cancer prevention/treatment.
An antioxidant carotenoid hypothesized to reduce oxidative stress and IGF-1 signaling implicated in prostate cell proliferation.
Dose: 15–30 mg
Tested as: Lycopene (tomato-derived carotenoid), commonly 15 mg/day in trials examining BPH progression/PSA, though preparations and co-formulations vary widely across the literature.
Zinc for Prostate Symptoms
Not verified1 study · 0 supporting · 0 against
Why it gets suggested: Zinc is theorized to inhibit 5-alpha-reductase and prolactin signaling in prostate tissue, based on laboratory rather than clinical evidence.
Dose: 10 mg
Tested as: No dedicated placebo-controlled trial of zinc monotherapy for BPH/LUTS was found. The only clinical trial evidence located tested zinc (10 mg/day) as one component of a fixed-dose combination with daidzein and isolase, not zinc alone.